These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27355875)

  • 1. Computational Study Exploring the Interaction Mechanism of Benzimidazole Derivatives as Potent Cattle Bovine Viral Diarrhea Virus Inhibitors.
    Wang J; Yang Y; Li Y; Wang Y
    J Agric Food Chem; 2016 Jul; 64(29):5941-50. PubMed ID: 27355875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
    Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
    Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp).
    Loddo R; Francesconi V; Laurini E; Boccardo S; Aulic S; Fermeglia M; Pricl S; Tonelli M
    Bioorg Med Chem; 2018 Feb; 26(4):855-868. PubMed ID: 29325885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replication.
    Paeshuyse J; Chezal JM; Froeyen M; Leyssen P; Dutartre H; Vrancken R; Canard B; Letellier C; Li T; Mittendorfer H; Koenen F; Kerkhofs P; De Clercq E; Herdewijn P; Puerstinger G; Gueiffier A; Chavignon O; Teulade JC; Neyts J
    J Virol; 2007 Oct; 81(20):11046-53. PubMed ID: 17686854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry.
    Pascual MJ; Merwaiss F; Leal E; Quintana ME; Capozzo AV; Cavasotto CN; Bollini M; Alvarez DE
    Antiviral Res; 2018 Jan; 149():179-190. PubMed ID: 29031833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antiviral evaluation and molecular docking studies of N
    Soraires Santacruz MC; Fabiani M; Castro EF; Cavallaro LV; Finkielsztein LM
    Bioorg Med Chem; 2017 Aug; 25(15):4055-4063. PubMed ID: 28600079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase.
    Musiu S; Castillo YP; Muigg A; Pürstinger G; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase.
    Wang Z; Chen Z; Li J; Huang J; Zheng C; Liu JP
    J Biomol Struct Dyn; 2020 Mar; 38(4):1071-1082. PubMed ID: 30915896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV).
    Tonelli M; Boido V; Colla P; Loddo R; Posocco P; Paneni MS; Fermeglia M; Pricl S
    Bioorg Med Chem; 2010 Mar; 18(6):2304-2316. PubMed ID: 20189812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication.
    Ibba R; Riu F; Delogu I; Lupinu I; Carboni G; Loddo R; Piras S; Carta A
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potent bovine viral diarrhea virus inhibitors by a structure-based virtual screening approach.
    Castro EF; Casal JJ; de Marco MJE; Battini L; Fabiani M; Fernández GA; Bruno AM; Cavallaro LV; Bollini M
    Bioorg Med Chem Lett; 2019 Jan; 29(2):262-266. PubMed ID: 30501966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems.
    Carta A; Briguglio I; Piras S; Corona P; Ibba R; Laurini E; Fermeglia M; Pricl S; Desideri N; Atzori EM; La Colla P; Collu G; Delogu I; Loddo R
    Eur J Med Chem; 2016 Jul; 117():321-34. PubMed ID: 27161176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase.
    Paeshuyse J; Leyssen P; Mabery E; Boddeker N; Vrancken R; Froeyen M; Ansari IH; Dutartre H; Rozenski J; Gil LH; Letellier C; Lanford R; Canard B; Koenen F; Kerkhofs P; Donis RO; Herdewijn P; Watson J; De Clercq E; Puerstinger G; Neyts J
    J Virol; 2006 Jan; 80(1):149-60. PubMed ID: 16352539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase.
    Giliberti G; Ibba C; Marongiu E; Loddo R; Tonelli M; Boido V; Laurini E; Posocco P; Fermeglia M; Pricl S
    Bioorg Med Chem; 2010 Aug; 18(16):6055-68. PubMed ID: 20638852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing the binding mode between respiratory syncytial virus fusion protein and benzimidazole-based inhibitors.
    Ji D; Ye W; Chen H
    Mol Biosyst; 2015 Jul; 11(7):1857-66. PubMed ID: 25872614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
    Zeng H; Zhang H; Jang F; Zhao L; Zhang J
    Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
    Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
    Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations induced in the NS5B gene of bovine viral diarrhea virus by antiviral treatment convey resistance to the compound.
    Newcomer BW; Neill JD; Marley MS; Ridpath JF; Givens MD
    Virus Res; 2013 Jun; 174(1-2):95-100. PubMed ID: 23524138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular mechanisms of inhibition of bovine viral diarrhea virus and hepatitis C virus RNA-dependent RNA polymerases by a novel benzimidazole.
    Asthana S; Shukla S; Vargiu AV; Ceccarelli M; Ruggerone P; Paglietti G; Marongiu ME; Blois S; Giliberti G; La Colla P
    Biochemistry; 2013 May; 52(21):3752-64. PubMed ID: 23627712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulation of bovine viral diarrhea virus--1 (BVDV-1) in dairy cattle and buffalo farms in Ismailia Province, Egypt.
    Soltan MA; Wilkes RP; Elsheery MN; Elhaig MM; Riley MC; Kennedy MA
    J Infect Dev Ctries; 2015 Dec; 9(12):1331-7. PubMed ID: 26719939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.